Milk allergy is the most common, affecting 2.5 percent of children under age 3. In a small clinical study, scientists report effectively desensitizing milk-allergic patients by increasing their exposure to milk in tandem with an allergy drug called omalizumab, allowing children to build up resistance quickly with limited allergic reactions.